Titlebook: Hepato-Pancreato-Biliary Malignancies; Diagnosis and Treatm Cataldo Doria,Jason N. Rogart Living reference work 20210th edition Hepatocell

審美家

書(shū)目名稱(chēng)Hepato-Pancreato-Biliary Malignancies影響因子(影響力)




書(shū)目名稱(chēng)Hepato-Pancreato-Biliary Malignancies影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Hepato-Pancreato-Biliary Malignancies網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Hepato-Pancreato-Biliary Malignancies網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Hepato-Pancreato-Biliary Malignancies被引頻次




書(shū)目名稱(chēng)Hepato-Pancreato-Biliary Malignancies被引頻次學(xué)科排名




書(shū)目名稱(chēng)Hepato-Pancreato-Biliary Malignancies年度引用




書(shū)目名稱(chēng)Hepato-Pancreato-Biliary Malignancies年度引用學(xué)科排名




書(shū)目名稱(chēng)Hepato-Pancreato-Biliary Malignancies讀者反饋




書(shū)目名稱(chēng)Hepato-Pancreato-Biliary Malignancies讀者反饋學(xué)科排名

充滿(mǎn)人

Hepatocellular Carcinoma Pathology,cal information needed at the time of surgery includes: (1) etiology of the underlying chronic liver disease, (2) location of tumor nodules on imaging, (3) history of neoadjuvant therapy and type of therapy, and (4) the presence or absence of a transjugular intrahepatic porto-systemic shunt (TIPS).

起草

Diagnosis and Evaluation of Hepatocellular Carcinoma,poses a significant burden to public healthcare. It is essential to have efficient and accurate tools to establish a diagnosis of HCC in a timely manner. As a result of surveillance protocols for patients at high risk for HCC, diagnostic algorithms can be initiated to allow for earlier confirmation

Indigence

壓碎

遵循的規(guī)范

Treatment of Liver Metastases from Colorectal Cancer,arge, and bilobar tumors; those with high CEA and tumors with multiple genetic mutations; and patients who present with synchronous CRLM. Aggressive surgical management along with improved systemic chemotherapy over recent years has improved overall survival. Many patients undergo multiple rounds of

addition

Treatment of Isolated Liver Metastasis from Non-colorectal Cancer,y contribute to a substantial portion of the modern hepatobiliary surgeon’s practice. Traditionally, metastatic liver lesions have portended a poor long-term prognosis. However, with advances in multimodal treatment of colorectal cancer, the most common primary site for metastatic liver lesions, as

多節(jié)

Epidemiology, Pathogenesis, and Prognosis of Uncommon Liver Tumors,are infrequently encountered. These lesions are often not discussed and less likely to be considered in the differential diagnosis of hepatic masses found either in symptomatic patients or incidentally. Given the rarity of some lesions, arriving at a definitive diagnosis and management plan can be p

缺陷

Clinical Presentation, Diagnosis, and Management of Uncommon Liver Tumors,patic lesions, arriving at a definitive diagnosis and management plan can be particularly challenging. In this chapter, we present an overview of clinical presentations, diagnosis, and management of uncommon hepatic tumors derived from available literature.

指數(shù)

Reducing the Risk of and Screening for Liver Cancer,irus (HBV) and hepatitis C virus (HCV), the incidence and death rates of hepatocellular carcinoma?(HCC) continue to increase. It is important to recognize and understand the risk factors that lead to the development of hepatocellular carcinoma. Many are modifiable by changes to lifestyle habits, pot